Vivos Therapeutics (VVOS) Capital Expenditures (2020 - 2026)
Vivos Therapeutics (VVOS) reported Capital Expenditures of $18000.0 for Q1 2026, down 85.25% year-over-year from $122000.0 in Q1 2025, and down 99.59% quarter-over-quarter from $4.4 million in Q4 2025.
Vivos Therapeutics (VVOS) Capital Expenditures (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Capital Expenditures data on file, last reported at $18000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $18000.0, down 85.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 million (up 842.67% YoY), and the FY2025 annual result was $5.2 million, up 812.85% from the prior year.
- Capital Expenditures eased to $18000.0 in Q1 2026 per VVOS's latest filing, from $4.4 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $4.4 million in Q4 2025 and troughed at -$588000.0 in Q4 2023.
- A 5-year average of $396764.7 and a median of $151000.0 in 2024 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures tumbled 394.0% in 2023, then jumped 2551.52% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $200000.0 in 2022, then plunged by 394.0% to -$588000.0 in 2023, then jumped by 128.06% to $165000.0 in 2024, then jumped by 2551.52% to $4.4 million in 2025, then plunged by 99.59% to $18000.0 in 2026.
- Business Quant data shows VVOS's Capital Expenditures at $18000.0 in Q1 2026, $4.4 million in Q4 2025, and -$83000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 4.38 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Sep 30, 2025 | -83,000.00 |
| Sep 30, 2025 | -83,000.00 |
| Jun 30, 2025 | 771,000.00 |
| Jun 30, 2025 | 771,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | 165,000.00 |
| Dec 31, 2024 | 165,000.00 |
| Sep 30, 2024 | 192,000.00 |
| Sep 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 151,000.00 |
| Mar 31, 2024 | 151,000.00 |
| Dec 31, 2023 | -588,000.00 |
| Dec 31, 2023 | -588,000.00 |